Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial (Q44168363)
Jump to navigation
Jump to search
scientific article published in October 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial |
scientific article published in October 2002 |
Statements
1 reference
Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial (English)
1 reference
D A Isenberg
1 reference
E H S Choy
1 reference
B Hazleman
1 reference
M Smith
1 reference
K Moss
1 reference
L Lisi
1 reference
D G I Scott
1 reference
J Patel
1 reference
M Sopwith
1 reference
1 October 2002
1 reference
1 reference
41
1 reference
10
1 reference
1133-1137
1 reference
Identifiers
1 reference
1 reference